HIF1A and ischemia: However, it is assumed that when the blood flow is adequate to provide oxygen supply to cells, HIF-1α will undergo quick degradation (45), explaining the significant reduction in its gene expression with BM-MSCs treatment compared with the ischemia group in the current study.